James J. Hyland, VP Investor Relations (636) 534-2369 Email: investor.relations@tlcvision.com
TLCVisionReports First Quarter 2008 EPS of $0.12 Per Share
Same-Store Procedure Growth up 9%
ST. LOUIS, MO, May 6, 2008:TLCVisionCorporation(NASDAQ:TLCV; TSX:TLC), North America’s premier eye care services company, today reported first quarter earnings of $0.12 per diluted share for the quarter ended March 31, 2008.
First Quarter 2008 Results
•
Revenue for the first quarter was $90.4 million, compared to $82.3 million for the prior year period, up 9.7%.
•
Refractive Centers revenue was $59.0 million, up 13.9% on the strength of higher majority-owned center procedures, which totaled 34,600 procedures in the first quarter, a 9% overall increase driven by a 9% increase on a same-store majority-owned basis. Average revenue per center procedure increased to $1,704, up 4.3% from the prior year period.
•
Doctor Services revenue increased 0.3% to $25.1 million on the strength of higher cataract procedures.
•
Eye Care revenue increased 13.5% to $6.3 million on the strength of increases in both the number of franchises and revenue per franchisee.
•
Consolidated net income for the first quarter was $6.1 million, compared to $3.5 million for the prior year period, up 75%. Earnings per diluted share for the first quarter were $0.12, compared to $0.05 for the prior year period, up 142%.
•
First quarter operating cash flow was $22.8 million, or $0.45 per share, compared to $15.3 million, or $0.22 per share, in the prior year period, up 49%.
•
Total debt was reduced during the first quarter by $6.9 million, or 6.2%.
Jim Wachtman, President and Chief Executive Officerof TLCVision, commented, “We are very pleased with the operating results for the first quarter. Over the past year and a half, our team has worked very hard to develop and execute a comprehensive strategy to grow the revenue of the company in order to better leverage our fixed cost infrastructure as well as drive both cash flow and earnings per share.
These results indicate the high operating leverage of our business model and its tremendous potential, especially in a stronger economic environment. We remain very focused on driving revenue growth, managing our costs, paying down debt and delivering shareholder value.”
Conference Call The Company will host a conference call and live web cast with investors and analysts on Tuesday, May 6, 2008 at 4:30 p.m. (EDT). To access, please dial 866-303-7746 or 416-641-6141 (international callers). The call will be broadcast live on the company’s web site atwww.tlcv.com under the “Webcasts” link in the Investor Relations section.
A replay of the conference call will be available until May 20, 2008. To access the replay, dial 800-408-3053 or 416-695-5800 (international callers) and enter the pass code: 3258680. The call will also be archived on the company’s web site atwww.tlcv.com under the “Webcasts” link in the Investor Relations section.
Forward Looking Statements
This press release contains certain forward looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, Section 21E of the U.S. Securities Exchange Act of 1934 and Canadian Provincial Securities Laws, which statements can be identified by the use of forward looking terminology, such as “may”, “will”, “expect”, ”intend”, “anticipate”, “estimate”, “predict”, “plans” or “continue” or the negative thereof or other variations thereon or comparable terminology referring to future events or results. We caution that all forward-looking information is inherently uncertain and that actual results may differ materially from the assumptions, estimates or expectations reflected in the forward-looking information. A number of factors could cause actual results to differ materially from those in forward-looking statements, including but not limited to economic conditions, the level of competitive intensity for laser vision correction, the market acceptance of laser vision correction, concerns about potential side effects and long term effects of laser vision correction, the ability to maintain agreements with doctors on satisfactory terms, quarterly fluctuation of operating results that make financial forecasting difficult, the volatility of the market price of our common shares, profitability of investments, successful execution of our direct-to-consumer marketing programs, the ability to open new centers, the reliance on key personnel, medical malpractice claims and the ability to maintain adequate insurance therefore, claims for federal, state and local taxes, compliance with industry regulation, compliance with U.S. and Canadian healthcare regulations, disputes regarding intellectual property, many of which are beyond our control.
Therefore, should one or more of theses risks materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results may vary significantly from what we currently foresee. Accordingly, we warn investors to exercise caution when considering any such forward-looking information herein and to not place undue reliance on such statements and assumptions. We are under no obligation (and we expressly disclaim any such obligation) to update or alter any forward-looking statements or assumptions whether as a result of new information, future events or otherwise, except as required by law.
See the Company’s reports filed with the Canadian Securities Regulators and the U.S. Securities and Exchange Commission from time to time for cautionary statements identifying important factors with respect to such forward looking statements, including certain risks and uncertainties, that could cause actual results to differ materially from results referred to in forward looking statements. TLCVisionassumes no obligation to update the information contained in this press release.
About TLCVision
TLCVisionis North America’s premier eye care services company, providing eye doctors with the tools and technologies needed to deliver high-quality patient care. Through its centers’ management, technology access service models, extensive optometric relationships, aggressive consumer advertising and managed care contracting strength, TLCVisionmaintains leading positions in Refractive, Cataract and Eye Care markets. Information about vision correction surgery can be found on the TLC Laser Eye Center’ website atwww.lasik.com. More information about TLCVisioncan be found on the Company’s website atwww.tlcv.com.
1
TLC VISION CORPORATION
CONSOLIDATING STATEMENTS OF OPERATIONS (UNAUDITED)
(In thousands, except per share amounts)
Three Months Ended March 31, 2008
Three Months Ended March 31, 2007
<root/>
Results Before AMD
Results Before AMD
Segment
AMD Segment
Total TLCVision
Segment
AMD Segment
Total TLCVision
Revenues:
Refractive centers
$
58,967
$
—
$
58,967
$
51,784
$
—
$
51,784
Doctor services
25,063
—
25,063
24,990
—
24,990
Eye care
6,325
—
6,325
5,572
—
5,572
Total revenues
90,355
—
90,355
82,346
—
82,346
Cost of revenues (excluding amortization):
Refractive centers
37,357
—
37,357
34,236
—
34,236
Doctor services
18,141
—
18,141
17,801
—
17,801
Eye care
2,822
—
2,822
2,475
—
2,475
Total cost of revenues (excluding amortization)
58,320
—
58,320
54,512
—
54,512
Gross profit
32,035
—
32,035
27,834
—
27,834
General and administrative
8,367
—
8,367
9,917
—
9,917
Marketing and sales
11,651
—
11,651
8,435
—
8,435
Amortization of intangibles
830
—
830
784
—
784
Other (income) expense, net
(197
)
—
(197
)
438
—
438
Total operating costs
20,651
—
20,651
19,574
—
19,574
Operating income
11,384
—
11,384
8,260
—
8,260
Interest income
210
—
210
568
—
568
Interest expense
(2,476
)
—
(2,476
)
(440
)
—
(440
)
Minority interests
(2,816
)
—
(2,816
)
(2,448
)
—
(2,448
)
Earnings (loss) from equity investments
217
—
217
811
(2,517
)
(1,706
)
Income (loss) from continuing operations before income taxes
6,519
—
6,519
6,751
(2,517
)
4,234
Income tax expense
(447
)
—
(447
)
(951
)
—
(951
)
Income (loss) from continuing operations
6,072
—
6,072
5,800
(2,517
)
3,283
Income from discontinued operations, net of tax
—
—
—
195
—
195
Net income (loss)
$
6,072
$
—
$
6,072
$
5,995
$
(2,517
)
$
3,478
Earnings (loss) per share — diluted
$
0.12
$
—
$
0.12
$
0.09
$
(0.04
)
$
0.05
Weighted average number of common shares outstanding — diluted
50,282
50,282
50,282
69,651
69,651
69,651
Note: The AMD segment includes the Company’s interest in OccuLogix, Inc.
TLC VISION CORPORATION
CONSOLIDATING BALANCE SHEETS
(In thousands)
March 31, 2008
December 31, 2007
Results Before AMD
Results Before AMD
AMD Segment
Segment
AMD Segment
Total TLCVision
Segment (Unaudited)
(Unaudited)
Total TLCVision
ASSETS
Current assets
Cash and cash equivalents
$
22,992
$
—
$
22,992
$
12,925
$
—
$
12,925
Accounts receivable, net
20,745
—
20,745
18,076
—
18,076
Prepaid expenses, inventory and other
14,404
—
14,404
14,882
—
14,882
Total current assets
58,141
—
58,141
45,883
—
45,883
Restricted cash
1,115
—
1,115
1,101
—
1,101
Investments and other assets
17,753
—
17,753
17,524
—
17,524
Goodwill
99,351
—
99,351
94,346
—
94,346
Other intangible assets, net
16,189
—
16,189
17,020
—
17,020
Fixed assets, net
59,583
—
59,583
61,936
—
61,936
Total assets
$
252,132
$
—
$
252,132
$
237,810
$
—
$
237,810
LIABILITIES
Current liabilities
Accounts payable
$
24,423
$
—
$
24,423
$
17,177
$
—
$
17,177
Accrued liabilities
34,611
—
34,611
28,115
—
28,115
Current maturities of long-term debt
7,744
—
7,744
11,732
—
11,732
Total current liabilities
66,778
—
66,778
57,024
—
57,024
Long-term debt, less current maturities
95,548
—
95,548
98,417
—
98,417
Other long-term liabilities
7,030
—
7,030
5,023
—
5,023
Minority interests
15,294
—
15,294
15,224
—
15,224
Total liabilities
184,650
—
184,650
175,688
—
175,688
STOCKHOLDERS’ EQUITY
Common stock
309,652
28,501
338,153
308,972
28,501
337,473
Option and warrant equity
745
—
745
837
—
837
Other comprehensive income
(2,084
)
—
(2,084
)
(784
)
—
(784
)
Accumulated deficit
(240,831
)
(28,501
)
(269,332
)
(246,903
)
(28,501
)
(275,404
)
Total stockholders’ equity
67,482
—
67,482
62,122
—
62,122
Total liabilities and stockholders’ equity
$
252,132
$
—
$
252,132
$
237,810
$
—
$
237,810
Note: The AMD segment includes the Company’s interest in OccuLogix, Inc.
TLC VISION CORPORATION
CONSOLIDATING STATEMENTS OF CASH FLOWS (UNAUDITED)
(In thousands, except per share amounts)
Three Months Ended March 31, 2008
Three Months Ended March 31, 2007
Results Before AMD
Results Before AMD
Segment
AMD Segment
Total TLCVision
Segment
AMD Segment
Total TLCVision
OPERATING ACTIVITIES
Net income (loss)
$
6,072
$
—
$
6,072
$
5,995
$
(2,517
)
$
3,478
Adjustments to reconcile net income (loss) to net cash from operating activities:
Depreciation and amortization
4,895
—
4,895
4,389
—
4,389
Minority interests
2,816
—
2,816
2,539
—
2,539
(Earnings) losses from equity investments
(217
)
—
(217
)
(811
)
2,517
1,706
Deferred taxes
—
—
—
851
—
851
Gain on sales and disposals of fixed assets
(69
)
—
(69
)
(88
)
—
(88
)
Gain on sale of businesses
(145
)
—
(145
)
—
—
—
Non-cash compensation expense
357
—
357
390
—
390
Other
251
—
251
15
—
15
Changes in operating assets and liabilities, net of acquisitions and dispositions:
8,846
—
8,846
2,019
—
2,019
Cash from operating activities
22,806
—
22,806
15,299
—
15,299
INVESTING ACTIVITIES
Purchases of fixed assets
(851
)
—
(851
)
(3,671
)
—
(3,671
)
Proceeds from sales of fixed assets
165
—
165
243
—
243
Distributions and loan payments received from equity investments
601
—
601
1,431
—
1,431
Acquisitions and equity investments
(2,984
)
—
(2,984
)
(2,718
)
—
(2,718
)
Proceeds from sales of short-term investments
—
—
—
3,225
—
3,225
Divestitures of businesses
1,179
—
1,179
—
—
—
Purchases of short-term investments
—
—
—
(3,750
)
—
(3,750
)
Other
29
—
29
(10
)
—
(10
)
Cash used in investing activities
(1,861
)
—
(1,861
)
(5,250
)
—
(5,250
)
FINANCING ACTIVITIES
Restricted cash movement
(14
)
—
(14
)
—
—
—
Principal payments of debt financing and capital leases
(13,199
)
—
(13,199
)
(1,926
)
—
(1,926
)
Proceeds from debt financing
5,384
—
5,384
167
—
167
Capitalized debt costs
(534
)
—
(534
)
—
—
—
Distributions to minority interests
(2,746
)
—
(2,746
)
(2,357
)
—
(2,357
)
Proceeds from issuances of common stock
231
—
231
122
—
122
Cash used in financing activities
(10,878
)
—
(10,878
)
(3,994
)
—
(3,994
)
Net increase in cash and cash equivalents during the period
10,067
—
10,067
6,055
—
6,055
Cash and cash equivalents, beginning of period
12,925
—
12,925
28,917
—
28,917
Cash and cash equivalents, end of period
$
22,992
$
—
$
22,992
$
34,972
$
—
$
34,972
Operating cash flow per diluted share
$
0.45
$
—
$
0.45
$
0.22
$
—
$
0.22
Note: The AMD segment includes the Company’s interest in OccuLogix, Inc.
2
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.